| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 06/24/2004 | CA2507607A1 Heterocyclic compounds, preparation method thereof and use of same as medicaments, such as anti-bacterial medicaments and beta-lactamaseinhibitors |
| 06/24/2004 | CA2505887A1 Pyrazole and imidazole compounds and uses thereof |
| 06/23/2004 | EP1430058A1 Sodium salt of an hiv integrase inhibitor |
| 06/23/2004 | EP1430053A1 Chemical compounds |
| 06/23/2004 | EP1430052A2 Substituted imidazo 1, 2-a]-5, 6, 7,8-tetrahydropyridine-8-ones, method for their production and the use thereof for producing imidazo 1, 2-a]pyridines |
| 06/23/2004 | EP1430050A1 Piperidine derivatives and their use as modulators of chemokine (especially ccr3) activity |
| 06/23/2004 | EP1429763A2 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 06/23/2004 | EP1429759A2 Compounds useful for treating hepatitus c virus |
| 06/23/2004 | CN1507447A Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 06/23/2004 | CN1154648C Stable crystal salt of 5-methyl tetrahydrofolic acid |
| 06/23/2004 | CN1154647C Imidazonephthyridines and their use in inducing cytokine biosynthesis |
| 06/23/2004 | CN1154646C Benzisozazoles and phenones as alpha antagonist |
| 06/22/2004 | US6753430 Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof |
| 06/22/2004 | US6753429 1,4-disubstituted benzenes as insecticides |
| 06/22/2004 | US6753427 2,6-disubstituted 7-oxopyrido(2,3-d)pyrimidines; inhibitors of protein kinases; treating diseases mediated by the pro-inflammatory cytokines, e.g., tumor necrosis factor, inter-leukins, cycloxygenase; chronic obstructive pulmonary disease |
| 06/22/2004 | US6753333 Arginine salt forms of s-(-)-9- fluoro-6,7-dihydro 8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1h,5h-benzo(i,j)quinolizine-2 -carboxylic acid, a process for their preparation and pharmaceutical formulations which are |
| 06/22/2004 | US6753331 Heterocyclic derivatives which inhibit factor Xa |
| 06/17/2004 | WO2004050681A2 Kinase modulators |
| 06/17/2004 | WO2004050658A1 Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments |
| 06/17/2004 | WO2004050656A1 1,3-dihydroimidazole fused-ring compound |
| 06/17/2004 | WO2004050651A1 Anilinopyrazole derivatives useful for the treatment of diabetes |
| 06/17/2004 | WO2004050650A1 Anilinopyrazole derivatives useful for the treatment of diabetes |
| 06/17/2004 | WO2004050629A2 The use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinence |
| 06/17/2004 | WO2004050623A1 Methods for preparing phenylalkyne derivatives |
| 06/17/2004 | WO2004050610A2 Modulators of melanocortin receptor |
| 06/17/2004 | WO2004050036A2 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
| 06/17/2004 | WO2004050035A2 Benzimidazoles and analogs thereof as antivirals |
| 06/17/2004 | WO2004018414A3 Antibacterial agents |
| 06/17/2004 | WO2004014869A3 5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors |
| 06/17/2004 | US20040116706 Therapeutic ureas |
| 06/17/2004 | US20040116698 6-Substituted pyrido-pyrimidines |
| 06/17/2004 | US20040116697 Novel compounds |
| 06/17/2004 | US20040116509 Antiviral agent; reducing the activity of viral polymerase; 3-(4-Chloro-2,5-dimethyl-benzenesulfonylamino)-5-(4-chloro-phenyl)-thiophene-2-carboxylic acid for example |
| 06/17/2004 | US20040116499 treatment of inflammatory or proliferative diseases of the skin and other organ systems; from yeast of the genus Malassezia; for example, 2,3-dihydro-4,5-bis(indol-3-yl)furan-2,3-dione; against multiresistent staphylococci |
| 06/17/2004 | US20040116493 Anti-helicobacterial agents |
| 06/17/2004 | US20040116474 Novel pyrazole compounds as transforming growth factor (TGF) inhibitors |
| 06/17/2004 | US20040116473 useful in the treatment of TGF- beta related disease states including, for example, cancer and fibrotic diseases |
| 06/17/2004 | US20040116467 Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents |
| 06/17/2004 | US20040116466 Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation |
| 06/17/2004 | US20040116465 Novel compounds |
| 06/17/2004 | US20040116463 excellent in stability than amorphous one and are more preferable for treatment of hyperlipidemia and atherosclerosis |
| 06/17/2004 | US20040116462 Antiinflammatory agents |
| 06/17/2004 | US20040116461 Immunomodulatory compounds |
| 06/17/2004 | US20040116458 Chemical compounds |
| 06/17/2004 | US20040116457 Agents for improving excretory potency of urinary bladder |
| 06/17/2004 | US20040116454 Pyrazole compounds useful as protein kinase inhibitors |
| 06/17/2004 | US20040116443 Dopamine D4 ligands for the treatment of novelty-seeking disorders |
| 06/17/2004 | US20040116438 Compositions for treatment of cell proliferation disorders |
| 06/17/2004 | US20040116429 5-Phenylpyrimidines, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi |
| 06/17/2004 | US20040116425 Prenylation inhibitors and methods of their synthesis and use |
| 06/17/2004 | US20040116410 Diazepinones as antiviral agents |
| 06/17/2004 | US20040116399 for preventing or treating coagulation disorders |
| 06/17/2004 | US20040116388 triazine compoound inhibitors of enzymes that catalyze phosphoryl transfer and/or that bind ATP/GTP nucleotides |
| 06/17/2004 | US20040116328 Condensed imidazole derivatives |
| 06/17/2004 | DE10256405A1 New 4-substituted quinoline derivatives, useful for treating bacterial infections, optionally including additional ring nitrogens |
| 06/17/2004 | DE10247233A1 New 4-substituted quinoline derivatives, useful for treating bacterial infections, optionally including additional ring nitrogens |
| 06/17/2004 | CA2508914A1 Modulators of melanocortin receptor |
| 06/17/2004 | CA2508311A1 The use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinence |
| 06/17/2004 | CA2507875A1 Methods for preparing phenylalkyne derivatives |
| 06/17/2004 | CA2507763A1 Fused 1,3-dihydro-imidazole ring compounds |
| 06/17/2004 | CA2507186A1 Anilinopyrazole derivatives useful for the treatment of diabetes |
| 06/17/2004 | CA2506546A1 Kinase modulators |
| 06/16/2004 | EP1428531A1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 06/16/2004 | EP1427729A1 Carbazole derivatives and their use as npy5 receptor antagonists |
| 06/16/2004 | EP1427726A1 Process for preparing 5-sulfonamido-8-hydroxy-1, 6-naphthyridine-7-carboxamides |
| 06/16/2004 | EP1427707A1 Substituted indazole compounds for the treatment of inflammation |
| 06/16/2004 | EP1427706A1 Substituted pyrazolo compounds for the treatment of inflammation |
| 06/16/2004 | EP1427421A1 2,4-disubstituted pyrimidinyl derivatives for use as anticancer agents |
| 06/16/2004 | EP1427415A1 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 06/16/2004 | EP1427414A1 Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines |
| 06/16/2004 | EP1427413A2 2-aroylimidazole compounds for treating cancer |
| 06/16/2004 | EP1427411A2 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo 3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 06/16/2004 | EP1427408A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$g(a) CONVERTING ENZYME (TACE) |
| 06/16/2004 | EP1427287A1 Pesticidal and parasitical di-and trifluorosubstituted alkene compounds |
| 06/16/2004 | EP1196418B1 METHOD FOR PREPARING SUBSTITUTED 1,4]DIAZEPINO 6,7,1- i hi /i ]INDOL-4-ONES |
| 06/16/2004 | EP1147083B1 Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
| 06/16/2004 | EP1109810B1 Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity |
| 06/16/2004 | EP0807105B1 Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists |
| 06/16/2004 | CN1505630A Pyrazolo[1,5-a]pyridines and medicaments containing thereof |
| 06/16/2004 | CN1505607A Peptide-deformylase inhibitors |
| 06/16/2004 | CN1505514A Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors |
| 06/16/2004 | CN1505511A Use of pyridoindolone derivatives for preparing medicines |
| 06/16/2004 | CN1505510A Medicine combinations using pyridoindolone derivatives and anticancer agent as base |
| 06/16/2004 | CN1505509A Method for treating allergies using substituted pyrazoles |
| 06/16/2004 | CN1153770C Substitued nitrogen heterocyclic ring as inhibitors of P38 protein kinase |
| 06/15/2004 | US6750348 Protective effects against infection by hiv through binding to chemokine receptors, including cxcr4 and ccr5;n-(2-pyridinylmethyl)-n'-(2-(phenylureido)ethyl)-n'-(5,6,7,8-tetrahydro-8-quinolinyl)-1,4-benzenedimethanamine |
| 06/15/2004 | US6750341 Preparation of risperidone |
| 06/15/2004 | US6750241 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic |
| 06/15/2004 | US6750228 Uncontrolled breakdown of connective tissue by metalloproteases is a feature of many pathological conditions |
| 06/15/2004 | US6750225 Anticoagulants |
| 06/15/2004 | US6750220 Amine salt of an integrin receptor antagonist |
| 06/15/2004 | US6750214 Quinoline and quinazoline compounds useful in therapy |
| 06/15/2004 | US6750005 Reagent system and method for increasing the luminescence of lanthanide(III) macrocyclic complexes |
| 06/15/2004 | US6749978 Electrophotographic organophotoreceptors with novel charge transport compounds |
| 06/15/2004 | CA2183735C Hetero-annulated indazoles |
| 06/10/2004 | WO2004048378A1 Pyrazoloquinolines with immunomodulating activity |
| 06/10/2004 | WO2004048377A2 Method of preparing inhibitors of phosphodiesterase-4 |
| 06/10/2004 | WO2004048376A1 Bicyclic naphthylidine nucleosides |
| 06/10/2004 | WO2004048375A1 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same |
| 06/10/2004 | WO2004048374A1 4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors |